InvestSMART

Golden parachute for CSL's boss

The long-serving chief executive of blood products and vaccine supplier CSL will take home $4.9 million in one-off payments when he severs ties with the company in October.
By · 29 Jun 2013
By ·
29 Jun 2013
comments Comments
Upsell Banner
The long-serving chief executive of blood products and vaccine supplier CSL will take home $4.9 million in one-off payments when he severs ties with the company in October.

Brian McNamee could also be awarded shares worth about $18 million in coming years under long-term incentive plans.

Dr McNamee's 23-year career as chief executive of CSL ended on Friday, and his contract with the company expires on October 15.

Under his leadership, CSL has grown from a small government enterprise to a listed company worth more than $30 billion.

Dr McNamee will be paid a $2.8 million severance payment as well as $2.1 million for nearly 200 days of untaken annual leave and sick leave.

He is also entitled to almost 125,500 performance rights and more than 179,000 performance options as part of long-term incentives, worth about $18 million.
Share this article and show your support
Free Membership
Free Membership
InvestSMART
InvestSMART
Keep on reading more articles from InvestSMART. See more articles
Join the conversation
Join the conversation...
There are comments posted so far. Join the conversation, please login or Sign up.